3. Crisis Control: VA-ECMO – An Ischemic Leg!

  • Post category:Episodes / MCS

CathMasters Drs. Nazli Okumus and Daniel Ambinder, along with expert faculty Drs. Ann Gage and Marwan Jumean, tackle the management of limb ischemia — one of the most feared complications of peripheral VA-ECMO (veno-arterial extracorporeal membrane oxygenation) and large-bore mechanical circulatory support (MCS). Through the case of a 50-year-old woman with ischemic cardiomyopathy on VA-ECMO and Impella CP who develops right leg ischemia, the team walks through bedside assessment of the ischemic limb, equipment and technique for placing a distal perfusion catheter (DPC) on an existing ECMO circuit, strategies to mitigate limb ischemia with Impella, assessment of vascular patency during large-bore access removal, and the recognition and management of compartment syndrome. Audio editing for this episode was performed by CardioNerds Intern, Dr. Julia Marques Fernandes

CathMasters is for educational purposes only.

CathMasters is for educational purposes only. Music by Elijah K from Pixabay

Pearls

  1. Limb ischemia on VA-ECMO is a clinical diagnosis made at the bedside. Compare the cannulated leg to the non-cannulated leg: assess color (pallor, mottling), temperature, capillary refill, and Doppler signals (dorsalis pedis and posterior tibial). Near-infrared spectroscopy (NIRS) provides continuous, objective monitoring — an absolute rSO2 <40%, a >20% drop from baseline, or a>15–20% difference between legs should prompt urgent evaluation.
  2. The distal perfusion catheter (DPC) should be the standard of care for all patients on femoral VA-ECMO. Prophylactic DPC reduces limb ischemia by ~60% (OR 0.31–0.41). When placing a DPC on a patient already on ECMO, use ultrasound-guided antegrade access into the superficial femoral artery (SFA) — the stick is more challenging with a large arterial cannula already in place, so patience and meticulous ultrasound technique are critical.
  3. For Impella CP, the 14F peel-away introducer sheath can be removed (“peeled away”), leaving only the smaller 9F repositioning sheath around the catheter. This simple maneuver may be sufficient to restore distal limb perfusion without the need for a separate DPC.
  4. After removing any large-bore access (TAVR sheath, Impella, ECMO cannula), consider performing completion angiography — ideally via radial or contralateral femoral access — to confirm vessel patency and rule out dissection, thrombosis, or stenosis before leaving the lab.
  5. Compartment syndrome on ECMO is paradoxically most dangerous after reperfusion, not during ischemia. When a DPC is placed in an ischemic limb, reperfusion causes cellular edema within fascial compartments. If compartment pressures exceed 20 mmHg (or are within 30 mmHg of diastolic blood pressure), emergency fasciotomy is required. Elevated CPK and lactate are late and concerning findings — do not wait for them.

Notes

1. Assessment of an Ischemic Limb

  • Limb ischemia occurs in approximately 10–20% of patients on peripheral VA-ECMO, historically 16.9% with fasciotomy needed in 10.3% and amputation in 4.7%. Contemporary data from high-volume centers using prophylactic DPC, smaller arterial cannulas, and ultrasound-guided access report limb ischemia rates as low as 3.5%.
  • The mechanism is multifactorial: the large arterial cannula (15–20F) partially or completely occludes the common femoral artery, reducing antegrade flow to the ipsilateral leg. Contributing factors include peripheral arterial disease (PAD), hemodynamic instability/low cardiac output, vasoconstriction from vasopressors, and thromboembolism.
  • Bedside assessment (compare cannulated vs. non-cannulated leg):
    • Inspection: Pallor, mottling, cyanosis, or dusky discoloration. Late findings include blistering and gangrene.
    • Palpation: Temperature differential (cool vs. warm), capillary refill time (>3 seconds is concerning), and palpation of pedal pulses.
    • Doppler assessment: Check dorsalis pedis (DP) and posterior tibial (PT) artery signals. Absent or monophasic signals on the cannulated side with normal signals contralaterally are highly concerning. Hourly Doppler checks should be standard nursing protocol.
    • NIRS monitoring: Near-infrared spectroscopy placed on the calves of both legs provides continuous, real-time tissue oxygen saturation (rSO2). An absolute rSO2 <40%, a drop >20% from baseline, or a difference >15–20% between legs should trigger urgent evaluation. Studies demonstrate that NIRS-guided DPC placement reduces limb ischemia requiring surgical intervention from 8.5% to 2.6% and eliminates the need for fasciotomy in monitored cohorts.
  • Laboratory markers: Elevated serum creatine phosphokinase (CPK) and lactate levels are late and very concerning findings, indicating that muscle necrosis has already begun. These should not be relied upon for early detection.
  • Risk factors for limb ischemia: PAD (OR 2.19), female sex, smaller vessel caliber, larger arterial cannula size, diabetes, and prolonged ECMO duration.

2. Equipment for Adding a DPC to a Patient on ECMO

  • Vascular ultrasound (linear probe)
  • Micropuncture access kit (21G needle, 0.018″ wire, 4–5F micropuncture sheath)
  • 0.035″ guidewire for exchange
  • Antegrade sheath: 5–8F braided sheath (braided sheaths resist kinking in the antegrade orientation). A 6F or 7F sheath is most commonly used.
  • Y-connector and arterial tubing to connect the DPC sheath side-arm to the arterial limb of the ECMO circuit
  • Fluoroscopy (if available) to confirm wire position in the SFA and rule out inadvertent entry into the profunda femoris
  • Sterile prep and drape for the ipsilateral groin/thigh
  • Sheath size selection: The DPC sheath should be large enough to provide adequate flow but small enough to avoid further vascular compromise. A 6–7F sheath is standard. The donor vessel (ECMO arterial limb) should ideally be a larger French size than the recipient (DPC sheath) to promote flow via a high-to-low pressure gradient.

3. Procedure for Adding a DPC to a Patient Already on ECMO

  • This is one of the more technically challenging sticks in interventional cardiology because the large arterial cannula already occupies the CFA, thereby limiting space and altering anatomy.
  • Step 1 — Position and prep: The patient is supine. Sterile prep of the ipsilateral groin and thigh. Identify the SFA distal to the arterial cannula insertion site using ultrasound.
  • Step 2 — Ultrasound-guided antegrade CFA-SFA access: Using a linear ultrasound probe, identify the SFA below the femoral bifurcation, distal to the ECMO arterial cannula. Perform an antegrade stick with a micropuncture needle. The key challenge is that the large cannula may compress or displace the SFA, and flow in the SFA may be diminished, making the vessel harder to visualize and access.
  • Step 3 — Wire and sheath placement: Advance the micropuncture wire and confirm position with fluoroscopy, if available (ensure the wire is in the SFA, not the profunda femoris). Exchange for a 0.035″ wire and place a 6–7F braided sheath in the antegrade direction.
  • Step 4 — Connect to circuit: Connect the side-arm of the DPC sheath to the arterial limb of the ECMO circuit using a Y-connector and arterial tubing. This diverts a portion of oxygenated, pressurized blood from the ECMO circuit into the distal leg.
  • Step 5 — Confirm perfusion: Reassess distal pulses by Doppler, check NIRS values, and assess clinical improvement (color, temperature, capillary refill). Improvement should be seen within minutes.
  • Alternative approaches if antegrade SFA access is not feasible:
    • Retrograde posterior tibial artery access with a 5–6F sheath
    • Contralateral femoral-to-ipsilateral SFA internal bypass (up-and-over technique): Retrograde access of the contralateral CFA with a 7F sheath, advance a 4–5F sheath up and over the aortic bifurcation into the ipsilateral SFA or profunda
    • Surgical cutdown with side-arm graft sewn onto the femoral artery

4. Ischemia Avoidance with Impella

  • Limb ischemia with Impella CP occurs in up to 12.5% of cases, primarily due to the occlusive 14F introducer sheath in the CFA.
  • Peel-away sheath technique: The Impella CP is inserted through a 14F peel-away introducer sheath. Once the device is positioned and secured, the outer 14F sheath can be “peeled away” (split and removed), leaving only the 9F repositioning sheath around the Impella catheter. This reduces the effective sheath size from 14F to 9F, which may be sufficient to restore adequate distal perfusion.
  • DPC configuration for Impella: If peeling away the sheath is insufficient, a DPC can be placed using the same antegrade SFA technique described above. The donor vessel options include:
    • Ipsilateral CFA: External bypass from the large-bore sheath side-port to the DPC sheath side-port using a male-to-male connector and arterial tubing
    • Contralateral femoral artery: External bypass to the antegrade ipsilateral SFA sheath
    • Contralateral femoral internal bypass: Up-and-over technique
  • General principles: Minimize arterial cannula/sheath size when possible, use ultrasound-guided access to ensure a clean CFA stick, and continuously monitor distal perfusion with NIRS and perform hourly Doppler checks.

5. Assessing Vascular Patency During/After Large-Bore Access Removal

  • Vascular complications after large-bore access removal (TAVR, Impella, VA-ECMO decannulation) are common and include thrombosis, dissection, stenosis, pseudoaneurysm, and distal embolization.
  • Strategies for assessment:
    • Pre-removal baseline: Document pedal pulses (Doppler DP and PT signals) and NIRS values on the ipsilateral leg before decannulation. Know what the baseline was so post-removal changes can be detected.
    • Completion angiography: After achieving hemostasis, perform angiography of the access vessel — ideally via radial access or contralateral femoral access. This confirms vessel patency, rules out dissection/thrombosis/stenosis, and identifies any residual thrombus. This is the single most important step.
    • Post-closure Doppler assessment: Immediately after closure, reassess pedal pulses. Loss of previously present signals warrants urgent angiography and potential intervention.
    • Protamine administration: After hemostasis is achieved, protamine can be used to reverse residual heparin effect and reduce oozing from the access site.
    • Dry-field closure technique: Via radial or contralateral femoral access, a peripheral balloon sized 1:1 with the ipsilateral external iliac artery can be inflated at 2–4 atm to achieve temporary hemostasis during deployment of suture-based closure devices, providing a controlled, bloodless field.
    • Post-procedure surveillance: Vascular duplex ultrasound within 24–48 hours to screen for pseudoaneurysm, AV fistula, or thrombosis may be considered. Late vascular complications occur in ~8% of survivors and may present weeks to months after discharge.

6. Compartment Syndrome and Fasciotomy

  • Compartment syndrome is a surgical emergency that occurs when pressure within a closed fascial compartment rises to a level that compromises tissue perfusion, leading to muscle necrosis and potentially limb loss.
  • Paradox of reperfusion: Compartment syndrome is rarely seen in profoundly ischemic limbs before reperfusion. It is most commonly triggered after reperfusion — when a DPC is placed in an ischemic limb, or when ECMO is initiated, and flow is restored. Reperfusion causes cellular edema, capillary leak, and swelling within the rigid fascial compartments of the lower leg.
  • Incidence: ECMO-associated compartment syndrome occurs in approximately 2.5% of all ECMO patients (598/24,047 in a national database study). Lower extremity compartment syndrome accounts for 85% of cases. Mortality in patients who develop ECMO-associated compartment syndrome is 58–65%.
  • Clinical findings: The limb becomes swollen and the skin taut. Pain out of proportion to exam (though often difficult to assess in sedated/intubated patients), pain with passive stretch of the compartment muscles, and a tense/woody feel to the compartment are classic findings.
  • Diagnosis:
    • Clinical suspicion is paramount — do not wait for laboratory confirmation.
    • Compartment pressure measurement: A pressure >20 mmHg warrants fasciotomy per the JACC Expert Panel. The ACC/AHA PAD guideline uses a delta pressure threshold (compartment pressure within 30 mmHg of diastolic blood pressure) as an alternative criterion.
    • Laboratory: Elevated CPK (often markedly elevated, >10,000 U/L) and rising lactate are late findings indicating muscle necrosis has already occurred. Myoglobinuria (dark urine) may be present.
  • Management:
    • Emergency four-compartment fasciotomy of the lower leg (anterior, lateral, superficial posterior, deep posterior) by a surgeon (vascular, orthopedic, or trauma surgery). Time to fasciotomy is critical — delays correlate with worse muscular findings and higher rates of amputation.
    • Prophylactic fasciotomy should be considered at the time of reperfusion in patients with prolonged ischemia (>4–6 hours) or severe tissue ischemia (Rutherford IIa/IIb).
    • Systemic consequences of reperfusion/rhabdomyolysis: Hyperkalemia, metabolic acidosis, acute kidney injury from myoglobin nephrotoxicity. Aggressive IV hydration and monitoring of electrolytes and renal function are essential.
    • If the limb is unsalvageable (extensive necrosis, gangrene), amputation may be necessary. Historically, 4.7% of VA-ECMO patients required amputation; contemporary rates at high-volume centers are <1%.

References

  1. ★ Guglin M, Zucker MJ, Bazan VM, et al. Venoarterial ECMO for adults: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73(6):698-716. doi:10.1016/j.jacc.2018.11.038
  2. ★ Damluji AA, Tehrani B, Sinha SS, et al. Position statement on vascular access safety for percutaneous devices in AMI complicated by cardiogenic shock. JACC Cardiovasc Interv. 2022;15(20):2049-2071. doi:10.1016/j.jcin.2022.08.040
  3. ★ Bonicolini E, Martucci G, Simons J, et al. Limb ischemia in peripheral veno-arterial extracorporeal membrane oxygenation: a narrative review of incidence, prevention, monitoring, and treatment. Crit Care. 2019;23(1):266. doi:10.1186/s13054-019-2541-3
  4. ★ Marbach JA, Faugno AJ, Pacifici S, et al. Strategies to reduce limb ischemia in peripheral venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. Int J Cardiol. 2022;361:77-84. doi:10.1016/j.ijcard.2022.04.084
  5. ★ Lamb KM, DiMuzio PJ, Johnson A, et al. Arterial protocol including prophylactic distal perfusion catheter decreases limb ischemia complications in patients undergoing extracorporeal membrane oxygenation. J Vasc Surg. 2017;65(4):1074-1079. doi:10.1016/j.jvs.2016.10.071
  6. ★ Vinogradsky A, Kurlansky P, Ning Y, et al. Continuous near-infrared reflectance spectroscopy monitoring to guide distal perfusion can minimize limb ischemia surgery for patients requiring femoral venoarterial extracorporeal life support. J Vasc Surg. 2023;77(5):1456-1465. doi:10.1016/j.jvs.2022.12.028
  7. Sohn B, Lee H. Near-infrared spectroscopy for preventing limb ischemia in extracorporeal membrane oxygenation. Artif Organs. 2025. doi:10.1111/aor.14978
  8. Kim DJ, Cho YJ, Park SH, et al. Near-infrared spectroscopy monitoring for early detection of limb ischemia in patients on veno-arterial extracorporeal membrane oxygenation. ASAIO J. 2017;63(5):613-617. doi:10.1097/MAT.0000000000000532
  9. Matthews R, Surti A, Bahroloomi D, et al. Contemporary practices and limb outcomes in peripheral venoarterial extracorporeal membrane oxygenation at a high-volume single institution. J Vasc Surg. 2026;83(4):1234-1242. doi:10.1016/j.jvs.2025.10.015
  10. Son AY, Khanh LN, Joung HS, et al. Limb ischemia and bleeding in patients requiring venoarterial extracorporeal membrane oxygenation. J Vasc Surg. 2021;73(2):669-676. doi:10.1016/j.jvs.2020.05.073
  11. Chanan EL, Bingham N, Smith DE, Nunnally ME. Early detection, prevention, and management of acute limb ischemia in adults supported with venoarterial extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth. 2020;34(11):3125-3132. doi:10.1053/j.jvca.2020.03.005
  12. ★ Seto AH, Estep JD, Tayal R, et al. SCAI position statement on best practices for percutaneous axillary arterial access and training. J Soc Cardiovasc Angiogr Interv. 2022;1(4):100365. doi:10.1016/j.jscai.2022.100365
  13. Davis HD, Habarth-Morales TE, Messa CA, Broach RB, Lin IC. Extracorporeal membrane oxygenation-associated compartment syndrome: review of a national database. J Surg Res. 2024;298:61-68. doi:10.1016/j.jss.2024.03.024
  14. ★ Writing Committee Members, Gornik HL, Aronow HD, et al. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease. J Am Coll Cardiol. 2024;83(24):2497-2604. doi:10.1016/j.jacc.2024.02.013
  15. Juo YY, Skancke M, Sanaiha Y, et al. Efficacy of distal perfusion cannulae in preventing limb ischemia during extracorporeal membrane oxygenation: a systematic review and meta-analysis. Artif Organs. 2017;41(11):E263-E273. doi:10.1111/aor.12942
  16. Balthazar T, Vandenbriele C, Verbrugge FH, et al. Managing patients with short-term mechanical circulatory support: JACC review topic of the week. J Am Coll Cardiol. 2021;77(9):1243-1256. doi:10.1016/j.jacc.2020.12.054
  17. Bernhardt AM, Copeland H, Deswal A, Gluck J, Givertz MM. The International Society for Heart and Lung Transplantation/Heart Failure Society of America guideline on acute mechanical circulatory support. J Card Fail. 2023;29(3):304-374. doi:10.1016/j.cardfail.2022.11.003
  18. Lorusso R, Whitman G, Milojevic M, et al. 2020 EACTS/ELSO/STS/AATS expert consensus on post-cardiotomy extracorporeal life support in adult patients. J Thorac Cardiovasc Surg. 2021;161(4):1287-1331. doi:10.1016/j.jtcvs.2020.09.045
  19. Wong JK, Smith TN, Pitcher HT, Hirose H, Cavarocchi NC. Cerebral and lower limb near-infrared spectroscopy in adults on extracorporeal membrane oxygenation. Artif Organs. 2012;36(8):659-667. doi:10.1111/j.1525-1594.2012.01496.x
  20. Cuculi F, Burkart P, Cioffi G, et al. Manual compression versus MANTA device for access management after Impella removal on the ICU. Sci Rep. 2022;12(1):14044. doi:10.1038/s41598-022-18316-z